OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 123 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,000 | -50.0% | 949 | 0.0% | 0.00% | – |
| Q4 2015 | $2,000 | -99.1% | 949 | -97.6% | 0.00% | – |
| Q4 2014 | $235,000 | -76.5% | 38,800 | -83.5% | 0.00% | -100.0% |
| Q3 2014 | $1,001,000 | +20.7% | 235,000 | +75.2% | 0.00% | 0.0% |
| Q2 2014 | $829,000 | +11742.9% | 134,140 | +10218.5% | 0.00% | – |
| Q4 2013 | $7,000 | -12.5% | 1,300 | 0.0% | 0.00% | – |
| Q3 2013 | $8,000 | -38.5% | 1,300 | -43.5% | 0.00% | – |
| Q2 2013 | $13,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
| Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
| Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
| KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
| PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
| APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
| FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
| JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
| Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |